MedPath

An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine

Phase 3
Completed
Conditions
Migraine Disorders
Interventions
Registration Number
NCT02565186
Lead Sponsor
Eli Lilly and Company
Brief Summary

This is a prospective, randomized, open-label study in subjects with migraine who have completed the Phase 3 studies, COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174) or for a subset of lasmiditan-naïve subjects with migraine. The study is designed to evaluate the safety and tolerability of long-term intermittent use of lasmiditan 100 mg and of lasmiditan 200 mg, as the first dose and as a second dose, for the acute treatment of migraine. Long term efficacy will also be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2171
Inclusion Criteria
  • Able and willing to give written informed consent and authorize Health Insurance Portability and Accountability Act (HIPAA).
  • Completed COL MIG-301 or COL MIG-302 within the last 12 weeks. Subjects that completed COL MIG-301 prior to COL MIG-305 being available will be allowed to enroll as long as enrollment occurs within 4 weeks of COL MIG-305 activation at their site. (NOTE: Additional subjects may qualify if they completed COL MIG-301 or COL MIG-302 >12 weeks prior or if they have not participated in either prior study, but meet eligibility criteria outlined for COL MIG-302.)
  • Females of child-bearing potential must be using or willing to use a highly effective form of contraception (e.g. combined oral contraceptive, intrauterine device (IUD), abstinence or vasectomized partner).
  • Able and willing to complete an electronic diary to record details of all migraine attacks treated with study drug.
Read More
Exclusion Criteria
  • Any medical condition or clinical laboratory test which in the judgment of the Investigator makes the subject unsuitable for the study.
  • Pregnant or breast-feeding women.
  • Women of child-bearing potential not using or not willing to use highly effective contraception.
  • Participant is at imminent risk of suicide (positive response to question 4 or 5 on the Columbia Suicide Severity Rating Scale (C-SSRS).
  • Initiation of or a change in concomitant medication to reduce the frequency of migraine episodes since completing COL MIG-301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174).
  • Participation in any clinical trial of an experimental drug or device since completing EoS/Visit 2 of COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lasmiditan 100mgLasmiditanParticipants received oral dose of 100 milligrams (mg) Lasmiditan with in four hours of onset of migraine attack. If the migraine did not respond within 2 hours after first dose or if responded and recurred then a second dose was permitted within 24 hours after first dose.
Lasmiditan 200mgLasmiditanParticipants received oral dose of 200mg Lasmiditan with in four hours of onset of migraine attack. If the migraine did not respond with in 2 hours after first dose or if responded and recurred then a second dose was permitted within 24 hours after first dose.
Primary Outcome Measures
NameTimeMethod
Number of Participants With at Least 1 Treatment Emergent Adverse EventUp to 12 months

An AE with an onset on or within 48 hours after a dose of study drug, or an event that worsened in intensity within 48 hours of a dose of study drug was considered a treatment-emergent adverse event (TEAE).

A summary of serious adverse events (SAEs) and other non-serious adverse events (AEs), regardless of causality, were reported in the Reported Adverse Events module.

Secondary Outcome Measures
NameTimeMethod
Percentage of Migraine Attacks With Most Bothersome Symptom-Free (MBS) at 2 Hours After DoseUp to 12 months

MBS-free, defined as the absence of the associated symptom of migraine (nausea, phonophobia, and/or photophobia) at 2 hours postdose that was identified predose as the most bothersome symptom.

Percentage of Migraine Attacks With Pain Freedom (PF) at 2 Hours After DoseUp to 12 months

Pain freedom is defined as a reduction in headache severity from mild (1), moderate (2), or severe (3) at baseline to none (0).

Trial Locations

Locations (159)

Medical Affiliated Research Center

🇺🇸

Huntsville, Alabama, United States

East Valley Family Physicians, PLC

🇺🇸

Chandler, Arizona, United States

Fountain Hills Family Practice, P.C.

🇺🇸

Fountain Hills, Arizona, United States

Anaheim Clinical Trials, LLC

🇺🇸

Anaheim, California, United States

The Research Center of Southern California

🇺🇸

Carlsbad, California, United States

eStudySite

🇺🇸

Chula Vista, California, United States

Allied Clinical Research

🇺🇸

Gold River, California, United States

Pacific Research Partners, LLC

🇺🇸

Oakland, California, United States

Desert Valley Research

🇺🇸

Rancho Mirage, California, United States

Northern California Clinical Research Center

🇺🇸

Redding, California, United States

Radiant Research - Vista CA

🇺🇸

Vista, California, United States

Anderson Clinical Research

🇺🇸

Redlands, California, United States

Encompass Clinical Research

🇺🇸

Spring Valley, California, United States

Neurological Research Institute

🇺🇸

Santa Monica, California, United States

Schuster Medical Research Institute

🇺🇸

Sherman Oaks, California, United States

Diablo Clinical Research

🇺🇸

Walnut Creek, California, United States

Colorado Springs Family Practice

🇺🇸

Colorado Springs, Colorado, United States

Alpine Clinical Research Center

🇺🇸

Boulder, Colorado, United States

Colorado Springs Health Partners, PC

🇺🇸

Colorado Springs, Colorado, United States

Nova Clinical Research, LLC

🇺🇸

Bradenton, Florida, United States

PAB Clinical Research

🇺🇸

Brandon, Florida, United States

Avail Clinical Research LLC

🇺🇸

DeLand, Florida, United States

Clinical Research West Coast

🇺🇸

Fort Myers, Florida, United States

MD Clinical

🇺🇸

Hallandale Beach, Florida, United States

Indago Research & Health Center, Inc.

🇺🇸

Hialeah, Florida, United States

Infinity Clinical Research, LLC

🇺🇸

Sunrise, Florida, United States

Veritas Research Corp

🇺🇸

Miami Lakes, Florida, United States

Ocean Blue Medical Research Center, Inc.

🇺🇸

Miami Springs, Florida, United States

Harmony Medical Research Institute, Inc

🇺🇸

North Miami Beach, Florida, United States

Clinical Research Center, LLC

🇺🇸

Royal Palm Beach, Florida, United States

Palm Beach Research Center

🇺🇸

West Palm Beach, Florida, United States

Synexus - US

🇺🇸

Columbus, Ohio, United States

Atlanta Center of Medical Research

🇺🇸

Atlanta, Georgia, United States

Columbus Regional Research Institute

🇺🇸

Columbus, Georgia, United States

Urban Family Practice Associates, PC

🇺🇸

Marietta, Georgia, United States

Harbin Clinic

🇺🇸

Rome, Georgia, United States

Pinnacle Trials, Inc

🇺🇸

Stockbridge, Georgia, United States

Georgia Neurology & Sleep Medicine Associates

🇺🇸

Suwanee, Georgia, United States

Evanston Premier Healthcare Research, LLC.

🇺🇸

Evanston, Illinois, United States

Clinical Investigation Specialists Inc

🇺🇸

Kenosha, Wisconsin, United States

Synexus/Clinical Research Advantage

🇺🇸

Evansville, Indiana, United States

Radiant Research, Inc.

🇺🇸

Council Bluffs, Iowa, United States

Heartland Research Associates

🇺🇸

Wichita, Kansas, United States

Continuum Health Care

🇺🇸

Overland Park, Kansas, United States

Research Integrity, LLC

🇺🇸

Owensboro, Kentucky, United States

Beacon Clinical Research, LLC

🇺🇸

Quincy, Massachusetts, United States

West Florissant Internists

🇺🇸

Bridgeton, Missouri, United States

Clinical Research Institute

🇺🇸

Plymouth, Minnesota, United States

Skyline Medical Center

🇺🇸

Elkhorn, Nebraska, United States

Nevada Family Care

🇺🇸

Henderson, Nevada, United States

Bio Behavioral Health

🇺🇸

Toms River, New Jersey, United States

Regional Clinical Research

🇺🇸

Endwell, New York, United States

Asheville Neurology Specialists, PA

🇺🇸

Asheville, North Carolina, United States

CNS Research Science, Inc.

🇺🇸

Jamaica, New York, United States

Rochester Clinical Research, Inc.

🇺🇸

Rochester, New York, United States

PMG Research of Cary, LLC

🇺🇸

Cary, North Carolina, United States

Lynn Institute of Norman

🇺🇸

Norman, Oklahoma, United States

Sunstone Medical Research, LLC

🇺🇸

Medford, Oregon, United States

Partners in Clinical Research, LLC

🇺🇸

Cumberland, Rhode Island, United States

West Bay Clinical Research

🇺🇸

Warwick, Rhode Island, United States

Lincoln Research

🇺🇸

Lincoln, Rhode Island, United States

Holston Medical Group Clinical Research

🇺🇸

Kingsport, Tennessee, United States

FutureSearch Trials

🇺🇸

Dallas, Texas, United States

ACRC Trials

🇺🇸

Plano, Texas, United States

Radiant Research - Dallas North

🇺🇸

Dallas, Texas, United States

Doctors of Internal Medicine

🇺🇸

Plano, Texas, United States

Protenium Clinical Research

🇺🇸

Hurst, Texas, United States

Plano Internal Medicine Associates

🇺🇸

Plano, Texas, United States

Ericksen Research and Development

🇺🇸

Clinton, Utah, United States

Jordan River Family Medicine

🇺🇸

South Jordan, Utah, United States

Charlottesville Medical Research

🇺🇸

Charlottesville, Virginia, United States

Multicare Health System

🇺🇸

Tacoma, Washington, United States

Synexus Clinical Research GmbH

🇩🇪

Berlin, Germany

Gemeinschaftspraxis für Neurologie und Psychiatrie

🇩🇪

Westerstede, Niedersachsen, Germany

Synexus Ltd

🇬🇧

Reading, Berkshire, United Kingdom

Alverton Practice

🇬🇧

Penzance, Cornwall, United Kingdom

Synexus Manchester Clinical Research Centre

🇬🇧

Manchester, Greater Manchester, United Kingdom

Kings College Hospital

🇬🇧

London, Greater London, United Kingdom

Synexus Merseyside Clinical Research Centre

🇬🇧

Waterloo, Merseyside, United Kingdom

Synexus Scotland Clinical Research Centre

🇬🇧

Glasgow, Strathclyde, United Kingdom

Synexus Wales Clinical Research Centre

🇬🇧

Cardiff, South Glamorgan, United Kingdom

Michigan Avenue Internists

🇺🇸

Chicago, Illinois, United States

Medical and Procedural Specialists of Illinois

🇺🇸

Chicago, Illinois, United States

Boston Clinical Trials

🇺🇸

Boston, Massachusetts, United States

Rapid Medical Research Inc

🇺🇸

Cleveland, Ohio, United States

Thomas C. Lenzmeier, M.D., P.C

🇺🇸

Glendale, Arizona, United States

Neurological Physicians of Arizona Inc

🇺🇸

Gilbert, Arizona, United States

Central Arizona Medical Associates, PC

🇺🇸

Mesa, Arizona, United States

Desert Clinical Research

🇺🇸

Mesa, Arizona, United States

Warner Family Practice

🇺🇸

Chandler, Arizona, United States

Arizona Community Physicians

🇺🇸

Tucson, Arizona, United States

Orange Grove Family Practice

🇺🇸

Tucson, Arizona, United States

Chase Medical Research, LLC

🇺🇸

Hamden, Connecticut, United States

Comprehensive Psychiatric Care, PC

🇺🇸

Norwich, Connecticut, United States

Clinical Neuroscience Solutions Inc

🇺🇸

Memphis, Tennessee, United States

Northwest Clinical Trials

🇺🇸

Boise, Idaho, United States

Advanced Clinical Research LLC

🇺🇸

Meridian, Idaho, United States

New Orleans Center for Clinical Research

🇺🇸

Knoxville, Tennessee, United States

Rita B. Chuang, MD LLC

🇺🇸

Henderson, Nevada, United States

Prairie Fields Family Medicine, PC

🇺🇸

Fremont, Nebraska, United States

Hassman Research Institute

🇺🇸

Berlin, New Jersey, United States

Coastal Carolina Research Center, Inc.

🇺🇸

Mount Pleasant, South Carolina, United States

Primary Care Associates

🇺🇸

Anderson, South Carolina, United States

Spartanburg Medical Research

🇺🇸

Spartanburg, South Carolina, United States

ClinSearch

🇺🇸

Chattanooga, Tennessee, United States

Mountain View Clinical Research, Inc.

🇺🇸

Greer, South Carolina, United States

Synexus Midlands Clinical Research Center

🇬🇧

Edgbaston, Birmingham, United Kingdom

Synexus Lancashire Clinical Research Centre

🇬🇧

Chorley, Lancashire, United Kingdom

Synexus Hexham General Hospital

🇬🇧

Hexham, Northumberland, United Kingdom

Pharmax Research Clinic

🇺🇸

Miami, Florida, United States

Prestige Clinical Research

🇺🇸

Miami, Florida, United States

Suncoast Research Group, LLC

🇺🇸

Miami, Florida, United States

Florida Medical Center and Research, Inc.

🇺🇸

Miami, Florida, United States

The Core Research Associates

🇺🇸

Miami, Florida, United States

Goldpoint Clinical Research LLC

🇺🇸

Indianapolis, Indiana, United States

Diagnostic Center of Medicine

🇺🇸

Las Vegas, Nevada, United States

Las Vegas Medical Research

🇺🇸

Las Vegas, Nevada, United States

California Research Foundation

🇺🇸

San Diego, California, United States

Artemis Institute for Clinical Research

🇺🇸

San Diego, California, United States

IVA Research

🇺🇸

Cincinnati, Ohio, United States

Family Practice Specialists Ltd

🇺🇸

Phoenix, Arizona, United States

Thunderbird Internal Medicine

🇺🇸

Phoenix, Arizona, United States

Tatum Highlands Medical Associates, PLLC

🇺🇸

Phoenix, Arizona, United States

21st Century Neurology

🇺🇸

Phoenix, Arizona, United States

Oklahoma City Clinic

🇺🇸

Oklahoma City, Oklahoma, United States

Central Phoenix Med Clinic LLC

🇺🇸

Phoenix, Arizona, United States

Clinical Trials of Texas, Inc.

🇺🇸

San Antonio, Texas, United States

Wasatch Clinical Research, LLC

🇺🇸

Salt Lake City, Utah, United States

Lynn Health Science Institute

🇺🇸

Oklahoma City, Oklahoma, United States

Nashville Neuroscience Group, Inc.

🇺🇸

Nashville, Tennessee, United States

Radiant Research - San Antonio

🇺🇸

San Antonio, Texas, United States

MacGregor Medical Center

🇺🇸

San Antonio, Texas, United States

Jean Brown Research

🇺🇸

Salt Lake City, Utah, United States

J. Lewis Research, Inc.

🇺🇸

Salt Lake City, Utah, United States

Simon Williamson Clinic

🇺🇸

Birmingham, Alabama, United States

Achieve Clinical Research, LLC

🇺🇸

Birmingham, Alabama, United States

Alabama Clinical Therapeutics

🇺🇸

Birmingham, Alabama, United States

Southview Medical Group

🇺🇸

Birmingham, Alabama, United States

Pharmacology Research Institute

🇺🇸

Newport Beach, California, United States

Mile High Primary Care

🇺🇸

Aurora, Colorado, United States

Clinical Trials of the Rockies

🇺🇸

Denver, Colorado, United States

Meridien Research

🇺🇸

Tampa, Florida, United States

Compass Research

🇺🇸

Orlando, Florida, United States

Meridian Clinical Research

🇺🇸

Omaha, Nebraska, United States

Michigan Head, Pain and Neurological Institute

🇺🇸

Ann Arbor, Michigan, United States

Medical Research South

🇺🇸

Charleston, South Carolina, United States

The Center For Pharmaceutical Research

🇺🇸

Kansas City, Missouri, United States

Clinical Trials of South Carolina

🇺🇸

Charleston, South Carolina, United States

Quality Clinical Research, Inc.

🇺🇸

Omaha, Nebraska, United States

Summit Research Network Inc

🇺🇸

Portland, Oregon, United States

Oregon Center for Clinical Investigations, Inc.

🇺🇸

Portland, Oregon, United States

Central Texas Clinical Research, LLC

🇺🇸

Austin, Texas, United States

Tekton Research, Inc

🇺🇸

Austin, Texas, United States

Clinical Research Partners, LLC

🇺🇸

Richmond, Virginia, United States

Central Kentucky Research Associates Inc

🇺🇸

Lexington, Kentucky, United States

Associates in Neurology, PSC

🇺🇸

Lexington, Kentucky, United States

Albuquerque Clinical Trials

🇺🇸

Albuquerque, New Mexico, United States

Thomas Jefferson University

🇺🇸

Philadelphia, Pennsylvania, United States

Radiant Research

🇺🇸

Murray, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath